186 related articles for article (PubMed ID: 20948309)
1. AMPK as a therapeutic target in renal cell carcinoma.
Woodard J; Joshi S; Viollet B; Hay N; Platanias LC
Cancer Biol Ther; 2010 Dec; 10(11):1168-77. PubMed ID: 20948309
[TBL] [Abstract][Full Text] [Related]
2. AMPK signaling: a targetable tumor suppressor pathway?
Schneider A; Gartenhaus RB
Cancer Biol Ther; 2010 Dec; 10(11):1178-81. PubMed ID: 21057216
[No Abstract] [Full Text] [Related]
3. AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival.
Woodard J; Platanias LC
Biochem Biophys Res Commun; 2010 Jul; 398(1):135-9. PubMed ID: 20599746
[TBL] [Abstract][Full Text] [Related]
4. Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production.
Fitzgerald JP; Nayak B; Shanmugasundaram K; Friedrichs W; Sudarshan S; Eid AA; DeNapoli T; Parekh DJ; Gorin Y; Block K
PLoS One; 2012; 7(1):e30712. PubMed ID: 22303451
[TBL] [Abstract][Full Text] [Related]
5. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
6. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
Dai YL; Huang SL; Leng Y
Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
[TBL] [Abstract][Full Text] [Related]
7. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
8. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
[TBL] [Abstract][Full Text] [Related]
9. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
[TBL] [Abstract][Full Text] [Related]
10. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
Faggi L; Giustina A; Tulipano G
Mol Cell Endocrinol; 2018 Jul; 470():60-74. PubMed ID: 28962892
[TBL] [Abstract][Full Text] [Related]
11. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
Guo D; Hildebrandt IJ; Prins RM; Soto H; Mazzotta MM; Dang J; Czernin J; Shyy JY; Watson AD; Phelps M; Radu CG; Cloughesy TF; Mischel PS
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12932-7. PubMed ID: 19625624
[TBL] [Abstract][Full Text] [Related]
12. Metabolic regulation of neuronal plasticity by the energy sensor AMPK.
Potter WB; O'Riordan KJ; Barnett D; Osting SM; Wagoner M; Burger C; Roopra A
PLoS One; 2010 Feb; 5(2):e8996. PubMed ID: 20126541
[TBL] [Abstract][Full Text] [Related]
13. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
15. LPS inhibits caspase 3-dependent apoptosis in RAW264.7 macrophages induced by the AMPK activator AICAR.
Russe OQ; Möser CV; Kynast KL; King TS; Olbrich K; Grösch S; Geisslinger G; Niederberger E
Biochem Biophys Res Commun; 2014 May; 447(3):520-5. PubMed ID: 24732361
[TBL] [Abstract][Full Text] [Related]
16. Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK).
Solskov L; Magnusson NE; Kristiansen SB; Jessen N; Nielsen TT; Schmitz O; Bøtker HE; Lund S
Mol Cell Biochem; 2012 Jan; 360(1-2):353-62. PubMed ID: 21964537
[TBL] [Abstract][Full Text] [Related]
17. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
[TBL] [Abstract][Full Text] [Related]
18. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
[TBL] [Abstract][Full Text] [Related]
19. Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling.
Sheng B; Liu J; Li GH
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):51-8. PubMed ID: 22564403
[TBL] [Abstract][Full Text] [Related]
20. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.
Habib SL; Yadav A; Kidane D; Weiss RH; Liang S
Cell Cycle; 2016 Nov; 15(22):3048-3059. PubMed ID: 27611085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
